NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
Go back to NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System| (NASDAQ: NRXP) | Delayed: 4.08 -0.4 (8.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.48 | 52 Week High | $ | |||
| Open | $4.35 | 52 Week Low | $ | |||
| Day High | $4.42 | P/E | N/A | |||
| Day Low | $4.02 | EPS | $ | |||
| Volume | 719,882 | |||||

